e-learning
resources
London 2016
Sunday, 04.09.2016
Airway biomarkers
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Breathprint of severe allergic asthma with SPME-GC-MS Analysis of exhaled air volatile organic compounds(Ege University translational pulmonology research group [EgeTPAG])
Özlem Göksel (Izmir, Turkey), Levent Pelit, Özlem Göksel, Tugberk Nail Dizdas, Ilknur Bagatir, Füsun Pelit, Hasan Ertas, Tuncay Göksel, Burak Ordin, Arif Gürsoy, Durmus Özdemir, Münevver Erdinç, F. Nil Ertas
Source:
International Congress 2016 – Airway biomarkers
Session:
Airway biomarkers
Session type:
Thematic Poster
Number:
1061
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Özlem Göksel (Izmir, Turkey), Levent Pelit, Özlem Göksel, Tugberk Nail Dizdas, Ilknur Bagatir, Füsun Pelit, Hasan Ertas, Tuncay Göksel, Burak Ordin, Arif Gürsoy, Durmus Özdemir, Münevver Erdinç, F. Nil Ertas. Breathprint of severe allergic asthma with SPME-GC-MS Analysis of exhaled air volatile organic compounds(Ege University translational pulmonology research group [EgeTPAG]). Eur Respir J 2016; 48: Suppl. 60, 1061
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Moleculer characterization of severe allergic asthma patients via exhaled breath volatile organic compounds(Ege University Translational Pulmonology Research Group [EgeTPRG])
Source: International Congress 2017 – Monitoring asthma control
Year: 2017
Identification of exhaled volatile organic compounds (VOCs) associated with loss of asthma control
Source: International Congress 2016 – Assessing lower airway inflammation with different tools
Year: 2016
Can exhaled volatile organic compounds predict asthma exacerbations in children?
Source: International Congress 2015 – Phenotyping asthma with biomarkers
Year: 2015
Measuring exhaled hydrogen sulphide (eH2S) levels in asthma
Source: International Congress 2016 – Airway biomarkers
Year: 2016
Exhaled breath condensate pH in assessment of childhood asthma control
Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease?
Year: 2014
Breath volatile organic compound (VOC) COPD study at two DZL centers - Evaluation of site-specific VOC
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015
Volatile organic compounds in exhaled breath samples as potential biomarkers in early diagnosis of lung cancer – (Ege translational pulmonology research group [EgeTPAG])
Source: International Congress 2016 – Prognostic variables in lung cancer II
Year: 2016
Repeated breath profiling by eNoses identifies asthma exacerbations and airway eosinophilia
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014
Unbiased clustering of severe asthma patients based on exhaled breath profiles
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015
Volatile organic compounds in exhaled breath of patients with COPD ± lung cancer and their correlation with FEV1-values
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
Usefulness of exhaled breath condensate as non-invasive method of evaluating of biomarkers in severe asthma patients
Source: International Congress 2014 – Biomarkers of asthma and clinical immunology
Year: 2014
Do volatile organic compounds (VOCs) discriminate between eosinophilic and neutrophilic asthma phenotype?
Source: International Congress 2015 – Phenotyping asthma with biomarkers
Year: 2015
Longitudinal changes in exhaled breath GC/MS profiles during loss of asthma control by prospective steroid withdrawal
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015
Metabolomic analysis of exhaled breath condensate in patients with asthma and COPD
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013
Exhaled breath temperature in asthmatic and healthy children: A case-control study
Source: International Congress 2014 – Paediatric asthma: markers and molecules
Year: 2014
Analysis of exhaled air for a rapid, sensible and specific diagnosis of COPD
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015
Exhaled breath VOCs are associated with nocturnal wakening in asthmatic children
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015
Number of particles in exhaled air is decreased by broncho-constriction
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013
Baseline exhaled NO in relation to asthma control improvement after increased dose of inhaled steroids – A real-life study
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013
Clinical application of hydrogen sulfide (H2S) as a marker of asthma management
Source: International Congress 2016 – Asthma points to ponder
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept